Literature DB >> 23987519

Cysteine-rich secretory protein 1 in seminal plasma: potential biomarker for the distinction between obstructive and nonobstructive azoospermia.

Christine Légaré1, Francine Cloutier, Sun Makosso-Kallyth, Nathalie Laflamme, Keith Jarvi, Roland R Tremblay, Robert Sullivan.   

Abstract

OBJECTIVE: To investigate the presence of cysteine-rich secretory protein 1 (CRISP1) in seminal plasma as a means of distinguishing between obstructive azoospermia (OA) and nonobstructive azoospermia (NOA).
DESIGN: Seminal plasma from normospermic donors (n = 45) and azoospermic donors (n = 80) was examined to determine CRISP1 levels. Neutral alpha-glucosidase (NAG) enzymatic activity was measured for comparison with CRISP1 levels.
SETTING: Research unit of an academic medical center. PATIENT(S): Normospermic and azoospermic donors from the clinical andrology laboratory of the centre hospitalier universitaire de Québec and from Mount Sinai Hospital. INTERVENTION(S): Seminal CRISP1 measurement by Western blot analysis. Neutral alpha-glucosidase activity was evaluated by a photometric method. MAIN OUTCOME MEASURE(S): Seminal plasma CRISP1 levels, NAG activity, cutoff value, sensitivity, and specificity. RESULT(S): All seminal plasma samples from normospermic and nonobstructive azoospermic donors were CRISP1 positive, whereas CRISP1 was absent or present at low levels in samples from patients with OA. A significant correlation between seminal CRISP1 levels and NAG activity was found in azoospermic semen samples. The cutoff point to distinguish between donors with NOA or OA was established at 0.655 (relative intensity). At this threshold, specificity was 85% and sensitivity was 92%. CONCLUSION(S): Seminal CRISP1 combined with NAG activity can potentially distinguish between OA and NOA.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Azoospermia; CRISP1; male infertility; seminal plasma

Mesh:

Substances:

Year:  2013        PMID: 23987519     DOI: 10.1016/j.fertnstert.2013.07.1984

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  The vasal fluid proteomic profile and microscopic sperm presence at time of vasectomy reversal.

Authors:  Theodore R Saitz; Kevin A Ostrowski; Ann Martinez Acevedo; Jasper C Bash; John Klimek; Eugene F Fuchs; Larry L David; Jason C Hedges
Journal:  Transl Androl Urol       Date:  2020-10

Review 2.  Omics in Seminal Plasma: An Effective Strategy for Predicting Sperm Retrieval Outcome in Non-obstructive Azoospermia.

Authors:  Reza Zarezadeh; Saba Nikanfar; Hajar Oghbaei; Yeganeh Rastgar Rezaei; Davoud Jafari-Gharabaghlou; Yadollah Ahmadi; Mohammad Nouri; Amir Fattahi; Ralf Dittrich
Journal:  Mol Diagn Ther       Date:  2021-04-15       Impact factor: 4.074

Review 3.  From the epididymis to the egg: participation of CRISP proteins in mammalian fertilization.

Authors:  Vanina G Da Ros; Mariana Weigel Muñoz; Maria A Battistone; Nicolás G Brukman; Guillermo Carvajal; Ludmila Curci; MatIas D Gómez-ElIas; D Bora J Cohen; Patricia S Cuasnicu
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

4.  Understanding the seminal plasma proteome and its role in male fertility.

Authors:  Mariana Camargo; Paula Intasqui; Ricardo Pimenta Bertolla
Journal:  Basic Clin Androl       Date:  2018-06-04

Review 5.  Exosome Composition and Seminal Plasma Proteome: A Promising Source of Biomarkers of Male Infertility.

Authors:  Luz Candenas; Rosanna Chianese
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.